Milkhaus Laboratory, Inc.

Other

Beech Tree Labs, Inc.

J & W Mcmichael Software Inc.

University Patents, Inc.

Molecular Rx, Inc.

Resolys Bio, Inc.

Milkhaus Laboratories, Inc.

Milkaus Laboratory, Inc.

John P McMichael

Harry C Gurney

Ellis L Kline

Allan D Lieberman

Michael Allen

Jean-Frederic Sauniere

James G Spaulding

A method is provided for treatment of symptoms of Ehlers-Danlos Syndromes comprising administration of a composition comprising rubeola virus, histamine and collagen.

Compositions and methods of treatment of Ehlers-Danlos syndromes

Disclosed herein is a method of inhibiting microglial cell migration in the brain of a mammalian subject in need thereof, including subjects suffering from the symptoms of traumatic brain injury (TBI) and subjects suffering from a hematoma in the brain comprising administering an effective amount streptolysin O (SLO) wherein microglial migration is inhibited providing therapeutic benefits to subjects suffering from diseases characterized by microglial cell migration and activation.

Method of inhibiting microglial cell migration and treating traumatic brain injury

Disclosed herein are methods of treating viral infections by administration of ethyl mercury or thiol derivative thereof in an amount effective to treat the viral infection.

Method of treating viral infections by administration of ethyl mercury or thiol derivative thereof

The present invention relates to a method of promoting bronchodilation by administration of streptolysin O to a subject in need thereof.

Method of treating chronic obstructive pulmonary disease

A method for administering nerve growth factor to treat cravings is provided. Pharmaceutical compositions for the treatment of cravings comprising nerve growth factor are also provided.

Method of treating cravings by administration of nerve growth factor

The invention provides a method for administering streptolysin O for treatment of various conditions including connective tissue disorders, reproductive fibroses and conditions mediated by the CD44 receptor. The invention also provides methods for protecting nerve cells from the effects of neurotoxic agents by the administration of streptolysin O.

Method of treatment of tendonitis by administration of streptolysin O

Method for administering streptolysin O for treatment of various conditions including connective tissue disorders, reproductive fibroses and conditions mediated by the CD44 receptor. The invention also provides methods for protecting nerve cells from the effects of neurotoxic agents by the administration of streptolysin O.

Method of treatment of conditions by administration of streptolysin O

The present invention is directed to methods of treating a chronic pelvic pain syndrome comprising the step of administering to a subject suffering from prostatis a chorionic gonadotropin or a pharmaceutically active fragment or derivative thereof in an amount effective to alleviate one or more symptoms of a chronic pelvic pain syndrome.

Method of treating chronic pelvic pain syndrome by administration of chorionic gonadotropin

Method for administering streptolysin O to treat various connective tissue disorders in humans and animals such as Dupuytren's contracture, scleroderma, Peyronie's disease, mastistis in animals, and claudication due to peripheral arterial disease.

Method of treatment of connective tissue disorders by administration of streptolysin O

The present invention provides methods and compositions for promoting bone regeneration, comprising administration of calmodulin. The method of bone regeneration is applied to subjects having bone disorders characterized by decreased bone mass such as osteopenia and osteoporosis, as well as those suffering from non-union fractures.

Use of calmodulin to promote bone regeneration

The invention provides methods and compositions for alleviating the symptoms of neuropathic conditions with a pharmaceutical composition including an effective amount of anti-glutamic acid decarboxylase (anti-GAD) antibodies.

Methods for alleviating symptoms associated with neuropathic conditions comprising administration of low levels of antibodies

The present invention relates to a treatment for patients having Lyme disease by administering a composition comprising an antigen at a sub-vaccine level effective to alleviate symptoms of Lyme disease.

Method for treatment of lyme disease

The invention provides methods and compositions for alleviating the symptoms of diabetes with a pharmaceutical composition including a combination of anti-glutamic acid decarboxylase (anti-GAD) and anti-insulin antibodies.

Methods for alleviating symptoms associated with diabetes and diabetic neuropathy comprising administration of low levels of antibodies

A method for treatment of symptoms of a respiratory disease or pain in a subject comprising administering to said subject a Substance P in an amount effective to alleviate those symptoms.

Methods of treatment comprising administration of Substance P

The present invention relates to a treatment for animals having canine distemper by administering a composition comprising an attenuated canine distemper virus a sub-vaccine virus level effective to alleviate symptoms canine distemper. The invention also provides a treatment for animals having canine distemper by administering a composition comprising an attenuated canine measles virus a sub-vaccine virus level effective to alleviate symptoms canine distemper.

Growing community of inventors

Wexford, PA, United States of America

John P McMichael